Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

642 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial.
Verstovsek S, Talpaz M, Wadleigh M, Isidori A, Te Boekhorst P, Savona MR, Bose P, Pozdnyakova O, Mesa R, El-Galaly TC, O'Sullivan J, Gamel K, Higgins B, Katakam S, Todorov B, Trunzer K, Harrison CN. Verstovsek S, et al. Among authors: bose p. Haematologica. 2024 Jun 1;109(6):1977-1983. doi: 10.3324/haematol.2023.284410. Haematologica. 2024. PMID: 38268448 Free PMC article. Clinical Trial. No abstract available.
Prognosis of Primary Myelofibrosis in the Genomic Era.
Bose P, Verstovsek S. Bose P, et al. Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S105-13. doi: 10.1016/j.clml.2016.02.031. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27521306 Free PMC article. Review.
Myelofibrosis: an update on drug therapy in 2016.
Bose P, Verstovsek S. Bose P, et al. Expert Opin Pharmacother. 2016 Dec;17(18):2375-2389. doi: 10.1080/14656566.2016.1252333. Epub 2016 Nov 7. Expert Opin Pharmacother. 2016. PMID: 27774820 Free PMC article. Review.
Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.
Jain P, Keating M, Renner S, Cleeland C, Xuelin H, Gonzalez GN, Harris D, Li P, Liu Z, Veletic I, Rozovski U, Jain N, Thompson P, Bose P, DiNardo C, Ferrajoli A, O'Brien S, Burger J, Wierda W, Verstovsek S, Kantarjian H, Estrov Z. Jain P, et al. Among authors: bose p. Lancet Haematol. 2017 Feb;4(2):e67-e74. doi: 10.1016/S2352-3026(16)30194-6. Epub 2017 Jan 12. Lancet Haematol. 2017. PMID: 28089238 Free PMC article. Clinical Trial.
642 results